Synthetic Biologics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Synthetic Biologics (TOVX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Synthetic Biologics
Tip: Access up to 7 years of quarterly data
All positions including Synthetic Biologics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Synthetic Biologics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $109 | 233 | 0.47 |
| 2023-12-31 | $98 | 231 | 0.43 |
| 2023-09-30 | $66 | 124 | 0.54 |
| 2023-06-30 | $109 | 109 | 1.00 |
| 2022-12-31 | $48 | 108 | 0.45 |
| 2022-09-30 | $0 | 105 | 0.00 |